Amgen’s newly created subsidiary, Pillartree Limited, will acquire Horizon Therapeutics for $116.50 per share in cash. That’s a premium of 19.7% above the closing price of $97.29 on Dec. 9, 2022.

While economic headwinds and rising interest rates have put a damper on mergers and acquisitions across the healthcare industry in the second half of 2022, health services deals are likely to be on the up and up next year.

Diagnostic catheters, ablation catheters and stents are just some of the solutions cardiologists are now struggling to obtain.

Ed Gaines, JD, vice president of regulatory affairs and industry liaison, Zotec Partners, discussed the impact of the 2023 Medicare Fee Schedule on radiology at RSNA 2022 in Chicago last week. RSNA and several other medical societies say the cuts are not sustainable.

A Northern California nurses union has approved their new employment deal with Kaiser Permanente after negotiating a 22.5% wage increase. 

Ed Gaines, JD, CCP, vice president of regulatory affairs and industry liaison, Zotec Partners, discusses the impact of the No Surprises Act on healthcare and medical imaging at the RSNA 2022 meeting

In 2006, the company started an iodine recycling program for imaging departments that had leftover contrast that would go to waste at the end of the day if left unused. That program expanded into the U.S. and Canada in 2021.

Their financial results are in stark opposition to several dismal reports about hospitals’ operating environments.